Colon Cancer ICD-10 Codes: Complete Guide to Accurate Diagnosis Coding

November 13, 2026

Colon-Cancer-ICD-10-Codes_-Complete-Guide-to-Accurate-Diagnosis-Coding-

Colon cancer claims can be rendered inaccurate prior to submission to the payer because a physician may indicate sigmoid colon cancer on the claim but the coding department picks a code for unspecified malignant neoplasm. On another claim, the claimant may have active cancer despite having received treatment many months ago.

ICD-10 codes for colon cancer include codes that belong to category C18, which is associated with malignant neoplasms according to their anatomical site. Code C18.9 is malignant neoplasm of the colon, unspecified, whereas codes for individual sites in the colon are provided.

It is also important for healthcare practitioners and coders to understand how active cancer, metastatic, carcinoma in situ, and personal history differ from each other.

What Is the ICD-10 Code for Colon Cancer?

The ICD-10-CM coding system codes malignant neoplasms of the colon using the code C18. The actual code depends on the location of the tumor.

For instance, C18.2 is the code for ascending colon cancer, while C18.7 is for sigmoid colon cancer, and C18.9 if the location is unspecified.

The CDC’s ICD-10-CM classification provides the official code set, while the CMS coding guidelines explain diagnosis reporting and sequencing requirements.

Colon Cancer ICD-10 Codes by Anatomical Location

The following table includes the active malignant neoplasm codes in category C18 for FY 2027, effective October 1, 2026, through September 30, 2027.

ICD-10-CM Code Official Diagnosis Description
C18.0 Malignant neoplasm of cecum
C18.1 Malignant neoplasm of appendix
C18.2 Malignant neoplasm of ascending colon
C18.3 Malignant neoplasm of hepatic flexure
C18.4 Malignant neoplasm of transverse colon
C18.5 Malignant neoplasm of splenic flexure
C18.6 Malignant neoplasm of descending colon
C18.7 Malignant neoplasm of sigmoid colon
C18.8 Malignant neoplasm of overlapping sites of colon
C18.9 Malignant neoplasm of colon, unspecified

Source: CDC FY 2027 ICD-10-CM Tabular List. Although the classification includes appendix cancer under C18.1, providers should not treat every appendix malignancy as conventional colon adenocarcinoma.

ftp.cdc.gov

When Should Providers Use C18.9?

Use of C18.9 should occur if there is documentation of colon cancer, but the body part is not specified.

For instance, a patient might have the following diagnosis on the chart: “Malignant neoplasm of colon.” The patient could be coded with C18.9. However, if the pathology report, operative findings, or physician’s documentation point to a specific location, it is best for the coder to determine that first.

C18.8 vs. C18.9: Why the Difference Matters

These codes represent varying scenarios.

  • C18.8: Represents a primary carcinoma which involves the colon segments but it is not possible to identify the origin of the tumor.
  • C18.9: Represents colon cancer without an identified specific site.

It is important to note that not every tumor that involves two contiguous colon segments qualifies for the use of code C18.8.

Colon Cancer vs. Rectal Cancer ICD-10 Codes

Providers frequently use “colorectal cancer” as a broad clinical term. ICD-10-CM, however, distinguishes colon, rectosigmoid junction, and rectal malignancies.

Cancer Location ICD-10-CM Code
Colon C18.0–C18.9
Rectosigmoid junction C19
Rectum C20

For instance, when the cancer is derived from the sigmoid colon, it can be coded as C18.7. However, cancer that arises from the rectosigmoid junction will have to be coded under C19. 

It is important for coders to look into the description provided by the doctor before coding either of these diagnoses.

Active Colon Cancer vs. Personal History of Colon Cancer

A previous colon cancer diagnosis does not automatically justify an active malignancy code.

Under the FY 2027 ICD-10-CM Official Guidelines, Coders should keep coding an active primary malignancy even if the patient is being treated for the same site.

After the patient undergoes treatment and the provider no longer detects any evidence of primary malignancy at that particular site, then a personal history code can be used.

Clinical Situation Coding Consideration
Active sigmoid colon malignancy C18.7
Active colon malignancy without specified site C18.9
Previous colon malignancy, eradicated, no further treatment Z85.038
Follow-up examination after completed cancer treatment Z08, with applicable history code

Z85.038 refers to personal history of other malignant neoplasms of the colon, which includes past history of primary malignancy, classified as C18.

Encounters subsequent to completion of cancer management procedures should consult coding guidelines for Z08 and appropriate history code.

How to Code Metastatic Colon Cancer

Colon cancer can metastasize into liver, lungs, lymph nodes, and elsewhere. Billing personnel should be able to differentiate between the primary cancer and its secondary sites where providers have identified metastases.

Secondary malignancy codes are as follows:

  • C78.7: Secondary malignant neoplasm of liver and intrahepatic bile duct.
  • C78.00: Secondary malignant neoplasm of unspecified lung.
  • C77.2: Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes.

Code selection should be based on the presence of the following conditions in the patient: active primary colon cancer, a cured primary cancer, or something else.

Example: Colon Cancer With Liver Metastasis

Patient treatment is targeted towards an actively progressing primary ascending colon cancer with a confirmed metastatic spread to the liver.

Coding can be done as follows:

  • C18.2 – Primary ascending colon cancer.
  • C78.7 – Secondary liver malignancy.

It depends on the treatment intent for the encounter as to whether the primary or the secondary cancer is coded first.

The CMS neoplasm sequencing guidelines explain these distinctions.

Centers for Medicare & Medicaid Services

Colon Carcinoma in Situ vs. Invasive Malignancy

Pathology report indicating carcinoma in situ cannot be used to prove colon cancer is invasive.

The following classification is used:

  • D01.0: Carcinoma in situ of colon.
  • D01.1: Carcinoma in situ of rectosigmoid junction.
  • C18.-: Invasive malignant neoplasm of colon, provided that the diagnosis is well documented.

Coding of high grade dysplasia, a benign adenoma or unconfirmed diagnosis cannot be interpreted as invasive colon cancer.

It is important to differentiate between these classifications when coding colonoscopy, polypectomy, pathology and oncology services.

Colon Cancer Coding Guidelines for Treatment Encounters

Diagnosis code alone is insufficient to make an oncology claim fully completed. The biller should sequence the diagnoses based on the purpose of the visit.

Chemotherapy and Immunotherapy

For the situation where the patient is coming to be seen mainly to receive antineoplastic chemotherapy, it is advised that the appropriate codes for such encounters should come first and they include:

  • Z51.11 – Encounter for antineoplastic chemotherapy
  • Z51.12 – Encounter for antineoplastic immunotherapy
  • Z51.0 – Encounter for antineoplastic radiotherapy

Also included is the diagnosis code for the malignant condition.

Colonoscopy and Cancer Screening

Billers should be able to tell the difference between colonoscopy screening and diagnosis.

In case where the patient visits the hospital for colorectal cancer screening but is asymptomatic or does not have cancer at that particular time, this is not the same situation as when the patient is visiting the hospital for colonoscopy as a result of bleeding or tumor.

The coders should always be aware of the purpose of the procedure, the findings, and the payer guidelines. C18.9 should never be coded just because the physician ordered for colonoscopy.

Common Colon Cancer ICD-10 Coding Errors

Coding Error Recommended Action
Using C18.9 despite documented location Select the supported anatomical code
Reporting active cancer after completed treatment Review personal history criteria
Confusing sigmoid cancer with rectosigmoid cancer Confirm the primary tumor site
Using primary liver cancer codes for metastases Identify the documented secondary malignancy
Coding suspected cancer as confirmed in outpatient care Follow outpatient uncertain-diagnosis rules
Sequencing active cancer first for every chemotherapy encounter Review treatment encounter guidelines

These errors can create diagnosis-to-service mismatches, prompt documentation requests, or contribute to denials under applicable payer policies.

How Can Providers Improve Colon Cancer Claim Accuracy?

Five major reviews may help providers and billers to make claims of high quality.

  1. Anatomical specificity. There must be adequate supporting documentation, surgical findings, and pathological report prior to selecting the code for the colon segment.
  2. Status of cancer. This must distinguish between ongoing treatment, completion of treatment, recurrence, and personal history.
  3. Metastatic disease. This must determine all sites of secondary lesions without assuming that the lesion determined by radiological method is metastatic.
  4. Sequence of diagnoses. This must ensure proper sequence of diagnoses in accordance with the purpose of the encounter and codes.
  5. Payer requirements. It is required to ensure the eligibility, authorization, procedure coding, and medical necessity before claim submission.

The medical billing process ensures proper coordination of documentation review, correction of codes and claims follow up without returning claims back to clinical staff.

Frequently Asked Questions 

1. What is the most common ICD-10 code for colon cancer?

C18.9 identifies malignant neoplasm of the colon, unspecified. More specific codes from the C18 category should be used when documentation supports a specific site.

2. What is the ICD-10 code for sigmoid colon cancer?

C18.7 identifies malignant neoplasm of the sigmoid colon. Care must be taken not to confuse this condition with rectosigmoid junction cancer, coded C19.

3. What ICD-10 code identifies the history of colon cancer?

Z85.038 identifies personal history of other malignant neoplasms of the large intestine. This code depends on whether there has been completed therapy and no current primary malignancy in that area.

4. Can providers code suspected colon cancer as confirmed?

Most guidelines for outpatient coding discourage coders from coding uncertain diagnoses as confirmed malignancies. Coders should use documented symptoms, findings, or any other reason for the visit until the physician makes an actual diagnosis.

5. Is colon cancer ICD-10 coding different from colorectal cancer coding?

Yes. The ICD-10-CM separates colon cancer under C18, rectosigmoid junction cancer under C19, and rectal cancer under C20.

6. Does C18.9 indicate the stage of colon cancer?

Code C18.9 refers to the anatomical diagnosis but does not provide information regarding the section of the colon involved. No stage of TNM is indicated.

Conclusion

Correct colon cancer ICD-10 coding starts with the location of the tumor; however, one must take into consideration the following information: treatment, metastasis, and the reason for visit.

When practitioners provide clear information on these factors, coders have an easier job when choosing diagnosis codes, thus reducing the likelihood of errors in claims.

Those practices that deal with coding corrections for oncology cases may benefit from reviewing their processes for documentation, claims, and denials management.

Are Colon Cancer Coding Errors Delaying Your Payments?

Incorrect ICD-10 codes, documentation gaps, and claim denials can disrupt oncology revenue. West Virginia Medical Billing helps your practice improve coding accuracy, manage denials, and streamline reimbursements.

Get a Free Medical Billing Assessment